Press Releases
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
IDEAYA Biosciences, Inc. and GlaxoSmithKline plc announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
The strategic partnership includes IDEAYAโs Synthetic Lethality...
Press Releases
Pfizer Announced FDA Approval of Oncology Supportive Care Biosimilar, NYVEPRIA
Pfizer Inc. announced the US FDA has approved NYVEPRIA, a biosimilar to Neulasta NYVEPRIA is indicated to decrease the incidence of infection, as manifested...
Press Releases
Sunovion Announces Health Canada Approval of KYNMOBI Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
Sunovion Pharmaceuticals Inc. announced that Health Canada has approved KYNMOBI soluble film for the acute, intermittent treatment of OFF episodes in patients with Parkinsonโs...
News
Dr. Reddys Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir
Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddyโs the...
News
Biocon and Mylan get U.S. FDA approval for insulin glargine injection
Mylan N.V. and Biocon Ltd. announced that the U.S. FDA has approved the New Drug Application (NDA) for Semglee (insulin glargine injection), in vial...
Press Releases
AstraZeneca to Supply Europe with 400M Doses of COVID-19 Vaccine
AstraZeneca has reached an agreement with Europeโs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















